Joel Morganroth

Author of Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents (Developments i

Ratings statistics

Click a column to sort by it.			Star Ratings
Title	Copies	Reviews	Ratings	Average	Median	Std. dev.
Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents (Developments i	1

No links yet.

Average: No ratings.

Joel Morganroth is currently considered a "single author." If one or more works are by a distinct, homonymous authors, go ahead and split the author.

Joel Morganroth is composed of 1 name.